September 11, 2024 at 2:13 pm

OS Therapies (OSTX) Releases Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Utilizing Tunable Antibody Drug Conjugate (tADC) Platform

The clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, OS Therapies (OSTX) today announced positive data in animal models of ovarian cancer for its first therapeutic candidate developed based upon its proprietary tunable Antibody Drug Conjugate (tADC) platform. The first therapeutic candidate leverages a folate receptor alpha targeting small molecule combined with hexa-exatecan payloads (OST-tADC-FRA-H) linked… [Read More]
September 11, 2024 at 11:49 am

Terns Pharmaceuticals Announces Public Offering Following Positive Data on Weight-Loss Drug

Terns Pharmaceuticals (Nasdaq: TERN) has announced an upsized public offering of 11.9 million shares of common stock at $10.50 per share, with expected gross proceeds of approximately $150.15 million. This announcement follows positive results from the company’s Phase 1 trial of its oral weight-loss drug, TERN-601, which demonstrated statistically significant weight loss and was well… [Read More]
September 10, 2024 at 1:23 pm

New Tilray Medical Study on Medical Cannabis Highlights Reduced Pain and Improved Sleep for Fibromyalgia Patients

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY) and a leading global player in the medical cannabis sector, recently released a new study, “Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS),”. The company’s mission is to connect patients with the latest scientific research in a more convenient way, aiming… [Read More]
September 10, 2024 at 10:25 am

Aclarion Technology Advances Global Validation with First Nociscan Exams in LIFEHAB Trial on Low Back Pain

The first six patients in randomized controlled trial completed Nociscan exams  Nociscan on track to be the gold standard for determining which discs to treat in research protocols on low back pain Aclarion, Inc. (Nasdaq: ACON), a healthcare technology company focused on leveraging biomarkers and augmented intelligence to identify chronic low back pain, announced the… [Read More]
September 09, 2024 at 1:10 pm

S&P 500 Climbs 1% as Dip Buyers Fuel Stock Rebound

Treasuries Hold Steady Amid Divided Sentiment on Fed Rate Cuts Focus Shifts to Inflation Data and Trump-Harris Debate A fresh wave of dip buying propelled stocks higher after an initial selloff triggered by economic worries. Investors are now turning their attention to upcoming inflation data, looking for signals on the Federal Reserve’s approach to rate… [Read More]
September 09, 2024 at 12:05 pm

Quoin Pharmaceuticals Announces Insider Share Purchases by CEO and COO, Highlighting Confidence in Company’s Growth

Quoin Pharmaceuticals (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company, announced that both of its cofounders, CEO Michael Myers and COO Denise Carter, have made significant purchases of the company’s American Depositary Shares (ADSs). On September 3 and 4, 2024, CEO Michael Myers acquired 37,894 ADSs, while COO Denise Carter purchased 37,735 ADSs.   These insider… [Read More]
September 09, 2024 at 8:59 am

Stocks making the biggest premarket moves: Boeing, Dell, Merck and more

Take a look at the businesses making major strides in premarket trading: Boeing’s shares surged 4% following a successful agreement with its factory workers’ union, a move that could potentially avert an expensive strike. MarineMax saw a surge in their shares by 6%, driven by Citi’s decision to upgrade their shares from neutral to buy…. [Read More]
September 06, 2024 at 8:48 pm

S&P 500 Poised for Worst Week Since March 2023 Amid Jobs Data Miss: Markets Wrap

Stocks tumbled toward their worst weekly decline since March 2023, as weaker-than-expected US labor data raised concerns about the slowing economy and the Federal Reserve’s response. The S&P 500 fell 1.5%, while the Nasdaq 100 dropped 2.4%, following news that August payroll growth missed forecasts by 23,000 jobs. This left the three-month average at its… [Read More]
September 06, 2024 at 10:44 am

Volkswagen (VWAGY) Looks to Hemp for Vehicle Interiors

Expanding its sustainability agenda, Volkswagen has turned to a German firm specializing in hemp. The aim: to create a leather substitute from cannabis to upholster car seats. Hemp pulp is already being used in the headliners of several car makers’ vehicles, and is being incorporated into more production processes for upcoming models. This project aligns… [Read More]
September 06, 2024 at 9:16 am

Lisata Therapeutics Secures FDA Orphan Drug Designation for Certepetide in Treating Aggressive Bile Duct Cancer

Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing therapies for advanced solid tumors, has announced that its investigational drug, certepetide, has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of cholangiocarcinoma, a rare and aggressive form of cancer. Cholangiocarcinoma, or bile duct cancer, forms in… [Read More]